Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2016

01-09-2016 | UNM Clinical Case Conferences

An Unexpected Cause of Fever and Elevated Liver Enzymes

Authors: Diego Colom-Steele, Didi Mwengela, Elizabeth Harris, Dino Beduya

Published in: Digestive Diseases and Sciences | Issue 9/2016

Login to get access

Excerpt

A 66-year-old male patient was referred from an outside facility for investigation of fever and abnormal liver tests. At the outside facility, he had been hospitalized for 5 days following the development of fever, chills, rigors, and intermittent confusion over the 3 weeks prior to presentation and had lost 30 lb over a 6-month period. He had no history of abdominal pain, jaundice, sick contacts, or recent travel. Laboratory tests showed serum concentrations of aspartate aminotransferase (AST) 153 IU/L (10–42 IU/L), alanine aminotransferase (ALT) 225 IU/L (10–40 IU/L), and alkaline phosphatase of 1108 IU/L (32–140 IU/L). One week prior to the evaluation at the referring facility, he had been admitted to another hospital suffering from fever and confusion: During admission there, laboratory test results had shown serum concentrations of total protein 5.7 gm/dL (5.7–8.2 gm/dL), albumin 2.6 gm/dL (3.2–4.8 gm/dL), AST 185 IU/L (15–45 IU/L), ALT 236 IU/L (17–63 IU/L), alkaline phosphatase 1294 IU/L (45–129 IU/L), total bilirubin 1.2 mg/dL (0.3–1.2 mg/dL), direct bilirubin 0.6 mg/dL (0.0–0.2 mg/dL), and λ-glutamyl transpeptidase (GGT) 757 IU/L (0–72.9 IU/L). Results of an abdominal ultrasound scan at that time were normal. Diagnosed as “fever of unknown origin,” a brief treatment with prednisone and ciprofloxacin was pursued, but a short time later he was transferred to our facility for further investigation and the treatment was discontinued. …
Literature
1.
go back to reference Lee WM, Larson AM, Stravitz RT. AASLD Position Paper: The Management of Acute Liver Failure: Update 2011. Baltimore, MD: American Association for the Study of Liver Diseases; 2011. Lee WM, Larson AM, Stravitz RT. AASLD Position Paper: The Management of Acute Liver Failure: Update 2011. Baltimore, MD: American Association for the Study of Liver Diseases; 2011.
2.
go back to reference George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;12:69–86.CrossRef George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;12:69–86.CrossRef
3.
go back to reference Schram AM, Campigotto F, Mullaly A, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125:1548–1552.CrossRefPubMed Schram AM, Campigotto F, Mullaly A, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125:1548–1552.CrossRefPubMed
4.
go back to reference de Kerguenec C, Hillaire S, Molinie V, et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol. 2001;96:852–857.CrossRefPubMed de Kerguenec C, Hillaire S, Molinie V, et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol. 2001;96:852–857.CrossRefPubMed
5.
go back to reference Schneier A, Stueck AE, Petersen B, et al. An unusual cause of acute liver failure: three cases of hemophagocytic lymphohistiocytosis presenting at a liver transplant center. Semin Liver Dis. 2016;36:99–106.CrossRefPubMed Schneier A, Stueck AE, Petersen B, et al. An unusual cause of acute liver failure: three cases of hemophagocytic lymphohistiocytosis presenting at a liver transplant center. Semin Liver Dis. 2016;36:99–106.CrossRefPubMed
6.
go back to reference Shabbir M, Lucas J, Lazarchick J, et al. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011;29:100–106.CrossRefPubMed Shabbir M, Lucas J, Lazarchick J, et al. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011;29:100–106.CrossRefPubMed
7.
go back to reference Roe C, Bennett J, Zhang L, et al. Hemophagocytic lymphohistiocytosis in malignant hematology: uncommon but should not be forgotten? Clin Lymphoma Myeloma Leukemia. 2015;15:147–150.CrossRef Roe C, Bennett J, Zhang L, et al. Hemophagocytic lymphohistiocytosis in malignant hematology: uncommon but should not be forgotten? Clin Lymphoma Myeloma Leukemia. 2015;15:147–150.CrossRef
8.
go back to reference Ichikawa S, Takahashi T, Katsushima H, et al. Advanced lymphocyte-rich classical Hodgkin lymphoma complicated with fatal hemophagocytic syndrome. Intern Med. 2016;55:191–196.CrossRefPubMed Ichikawa S, Takahashi T, Katsushima H, et al. Advanced lymphocyte-rich classical Hodgkin lymphoma complicated with fatal hemophagocytic syndrome. Intern Med. 2016;55:191–196.CrossRefPubMed
Metadata
Title
An Unexpected Cause of Fever and Elevated Liver Enzymes
Authors
Diego Colom-Steele
Didi Mwengela
Elizabeth Harris
Dino Beduya
Publication date
01-09-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4253-8

Other articles of this Issue 9/2016

Digestive Diseases and Sciences 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.